help button home button The Oncologist http://theoncologist.alphamedpress.org/misc/eLetters.shtml
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

The Oncologist, Vol. 11, No. 8, 957, September 2006; doi:10.1634/theoncologist.11-8-957
© 2006 AlphaMed Press

This Article
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, J. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Brown, J. R.

Letter to the Editor

In Reply

Jennifer R. Brown

Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Correspondence: Jennifer R. Brown, M.D., Ph.D., Dana-Farber Cancer Institute, 44 Binney St. D1B18, Boston, Massachusetts 02115, USA. Telephone: 617-632-4894; Fax: 617-582-7909 e-mail: jbrown2{at}partners.org

Received June 28, 2006; accepted for publication July 10, 2006.

In their letter, Gruber et al. [1] present data on the significant risk for lymphoma development in patients with lymphomatoid papulosis. Given this risk, they conclude that treatments are needed to prevent the development of systemic lymphoma. However, it should be noted that no currently available treatment for lymphomatoid papulosis has been shown to alter the natural history of the disease [2]. Furthermore, by analogy to indolent B-cell lymphomas, therapy does not appear to alter the risk for transformation to a more aggressive histology [3]. Unfortunately, therefore, more aggressive therapy of lymphomatoid papulosis may not prevent the development of aggressive lymphoma.


    DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST
 Top
 Disclosure of Potential...
 References
 
The author indicates no potential conflicts of interest.


    REFERENCES
 Top
 Disclosure of Potential...
 References
 

  1. Gruber R, Sepp NT, Fritsch PO et al. Prognosis of lymphomatoid papulosis. The Oncologist 2006;11:955–957.[Free Full Text]
  2. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–3785.[Abstract/Free Full Text]
  3. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N Engl J Med 1984;311:1471–1475.[Abstract]




This Article
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, J. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Brown, J. R.


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl